Teva

Teva collaborates on skin disease treatment, releases targets

Under the agreement with Royalty Pharma, the companies will jointly develop the anti-IL-15 antibody, TEV-'408, which is in a phase 1b trial for the treatment of vitiligo

Logo of Teva Pharmaceutical
Logo of Teva Pharmaceutical

Teva seeks startups to help solve global pharmaceutical challenges

The Resilience Acceleration program in Teva’s offices

Placing the focus on the therapist

 Illustrative photo shows various medicine pills in their original packaging

Does a common heart attack pill help everyone? Studies disagree


Teva collaborates with Technion in fields of cancer, neurobiology

Teva has already initiated collaborations with leading academic institutions, including Tel Aviv University, the Weizmann Institute of Science, and more.

An Israeli flag flutters near the logo of Teva Tech which is part of Teva Pharmaceutical Industries in Neot Hovav, southern Israel December 14, 2017.

Israeli researchers provide evidence microdosing cannabis relieves pain

The researchers published their findings in the European Journal of Pain, providing the first scientific evidence that microdosing can be applied medical cannabis solution.

Chemdawg marijuana plants grow at a facility

Teva Israel sues Abbott over baby formula

Teva is claiming that Abbott Israel, a local entity which imports Similac, is behind a “mendacious and covert slur campaign” on social media.

Nutrilon

Teva Naot opens fourth branch in Japan

Teva Naot markets about 100 different models of Japanese women’s fashion shoes.

THE COMPANY offers 100 different models of Japanese women’s fashion shoes.

Florida has not distributed most of hydroxychloroquine doses from Israel

Only a handful of hospitals have requested access to the hydroxychloroquine stockpile, according to the report.

The drug hydroxychloroquine, pushed by U.S. President Donald Trump and others in recent months as a possible treatment to people infected with the coronavirus disease (COVID-19), is displayed by a pharmacist at the Rock Canyon Pharmacy in Provo, Utah, US, May 27, 2020

Teva gets approval in China for Huntington's disease treatment

Teva’s CEO Kare Schultz said the drug would be priced somewhat lower in China than in the United States.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

Teva's profit beats forecasts, shares jump

Shares in the world’s largest generic drugmaker jumped nearly 20% in late Tel Aviv trade as the company also reaffirmed its 2020 outlook, despite disruption to the global economy from the coronavirus

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

Teva donates potential coronavirus treatment to hospitals across the US

Hydroxychloroquine sulfate tablets are used against malaria, lupus erythematosus and rheumatoid arthritis but could be effective against COVID-19.

A building belonging to generic drug producer Teva, Israel's largest company with a market value of about $57 billion, is seen in Jerusalem

After turbulent years, Teva CEO Schultz forecasts stability

Teva completed its two-year major restructuring plan in 2019, reducing its cost base by over $3 billion and net debt by more than $9b.

Teva CEO Kåre Schultz at the Tel Aviv Stock Exchange, February 19, 2020

Teva's first ever National Forum for Bio-Innovators gathers in Tel Aviv

Researcher Hila Flayev has for years been conducting research on computational models of the coronavirus structure and interactions it can create.

Teva's first ever National Forum for Bio-Innovators gathers in Tel Aviv